Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Spontaneous ADR reporting in the spotlight

    • 5 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Spontaneous ADR reporting in the spotlight. React. Wkly. 735, 3–4 (1999). https://doi.org/10.2165/00128415-199907350-00004

    Download citation

    Keywords

    • Phenylbutazone
    • Spontaneous Reporting
    • International Drug Monitoring
    • Market Withdrawal
    • Sequence Inversion